MIT Researchers Engineer Donor Immune Cells to Wipe Out Cancer Cells
Immunotherapy has transformed cancer treatment, but the approach still faces challenges like lengthy preparation time (time that patients often don’t have), safety issues that result in discontinuation of treatment, and lack of responsiveness in many patients. Scientists are looking for ways to improve this approach, and MIT researchers seem to have come up with a viable improvement. The study, whose findings appeared in the journal Nature Communications, suggests that the researchers may have developed a way to prepare CAR-NK (chimeric antigen receptor natural killer) cells in advance so that once a patient needs this treatment, the ready-to-use modified immune cells…
